Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data — Mark A. Smith (2018) | RDL Network
Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data
Article 2018 en
Authors
MS
Mark A. Smith
RB
Richard L. Bowen
RN
Richard Q. Nguyen
Abstract
1 min read
Patients with prostate cancer are treated with the GnRH analogue leuprolide acetate, our data suggest that leuprolide acetate may be therapeutic for AD via its downregulation of serum gonadotropins.
Discussion(0)
No comments yet. Be the first to comment.